Maternal Delta-9-Tetrahydrocannabinol Exposure Induces Abnormalities of the Developing Heart in Mice.

Cannabis Cannabinoid Res

Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, Canada.

Published: February 2024

Cannabis is increasingly being consumed by pregnant women for recreational purposes as well as for its antiemetic and anxiolytic effects despite limited studies on its safety during pregnancy. Importantly, phytocannabinoids found in cannabis can pass through the placenta and enter the fetal circulation. Recent reports suggest gestational cannabis use is associated with negative fetal outcomes, including fetal growth restriction and perinatal intensive care, however, the effects of delta-9-tetrahydrocannabinol (THC) on fetal heart development remains to be elucidated. We aimed to determine the outcomes of maternal THC exposure on fetal heart development in mice by administering 0, 5, or 10 mg/kg/day of THC orally to C57BL/6 dams starting at embryonic day (E)3.5. Offspring were collected at E12.5 for molecular analysis, at E17.5 to analyze cardiac morphology or at postnatal day (PND)21 to assess heart function. Maternal THC exposure in E17.5 fetuses resulted in an array of cardiac abnormalities with an incidence of 44% and 55% in the 5 and 10 mg/kg treatment groups, respectively. Maternal THC exposure in offspring resulted in ventricular septal defect, higher semilunar valve volume relative to orifice ratio, and higher myocardial wall thickness. Notably, cell proliferation within the ventricular myocardium was increased, and expression of multiple cardiac transcription factors was downregulated in THC-exposed E12.5 fetuses. Furthermore, heart function was compromised with lower left ventricular ejection fraction, fractional shortening, and cardiac output in PND21 pups exposed to THC compared to controls. The results show that maternal THC exposure during gestation induces myocardial hyperplasia and semilunar valve thickening in the fetal heart and postnatal cardiac dysfunction. Our study suggests that maternal cannabis consumption may induce abnormalities in the developing heart and cardiac dysfunction in postnatal life.

Download full-text PDF

Source
http://dx.doi.org/10.1089/can.2022.0180DOI Listing

Publication Analysis

Top Keywords

maternal thc
16
thc exposure
16
fetal heart
12
abnormalities developing
8
developing heart
8
heart development
8
heart function
8
semilunar valve
8
cardiac dysfunction
8
heart
7

Similar Publications

Differential effects of gestational Cannabis smoke and phytocannabinoid injections on male and female rat offspring behavior.

Prog Neuropsychopharmacol Biol Psychiatry

January 2025

Department of Anatomy, Physiology, and Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada. Electronic address:

Our understanding of the implications of gestational Cannabis exposure (GCE) remains unclear as Cannabis use increases worldwide. Much of the existing knowledge of the effects of GCE has been gained from preclinical experiments using injections of isolated Δ-tetrahydrocannabinol (THC) at relatively high doses. Few investigations of the effects of GCE to smoke from the whole Cannabis flower have been conducted, despite this being the most common mode of human consumption.

View Article and Find Full Text PDF

Unlabelled: Maternal immune activation (MIA) commonly arises in response to an infection during pregnancy. MIA elevates cytokine levels, triggering an inflammatory cascade, which may be detrimental to the developing nervous system. Similarly, cannabis use and exposure of the fetus to cannabinoids during pregnancy (PCE) may elicit neuroinflammation and lead to detrimental behavioral outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Δ-Tetrahydrocannabinol (THC) is the main psychoactive ingredient in cannabis, and its usage among pregnant individuals is rising, leading to concerns about fetal exposure.
  • Research indicates that fetal THC exposure is significantly lower than maternal levels due to a specific placental transporter that actively reduces THC transfer to the fetus, although the exact identity of this transporter remains unknown.
  • In lab studies, it was discovered that THC and its metabolite THC-COOH acted as substrates for certain liver transporters but were not inhibitors, highlighting the complexity of THC metabolism and transport in the body.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!